|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Acumen Pharmaceuticals, Inc. (ABOS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
40,470,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Acumen Pharmaceuticals discovers and develops targeted therapies for the treatment of Alzheimer's disease. Co.'s primary drug candidate, ACU193, is a humanized monoclonal antibody which selectively targets amyloid-beta oligomers. Co. holds exclusive rights to the program.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
5,161,290 |
5,161,290 |
| Total Buy Value |
$0 |
$0 |
$39,999,998 |
$39,999,998 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
34,332 |
76,281 |
76,281 |
| Total Sell Value |
$0 |
$121,677 |
$394,011 |
$394,011 |
| Total People Sold |
0 |
5 |
6 |
6 |
| Total Sell Transactions |
0 |
5 |
6 |
6 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Oconnell Daniel Joseph |
President and CEO |
• • – |
2024-01-19 |
4 |
AS |
$3.47 |
$52,753 |
D/D |
(15,200) |
502,485 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2024-01-19 |
4 |
AS |
$3.48 |
$31,048 |
D/D |
(8,933) |
108,867 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2024-01-18 |
4 |
AS |
$3.73 |
$10,555 |
D/D |
(2,833) |
96,867 |
|
- |
|
| Siemers Eric |
Chief Medical Officer |
• – – |
2024-01-18 |
4 |
AS |
$3.71 |
$11,604 |
D/D |
(3,124) |
117,576 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2024-01-18 |
4 |
AS |
$3.71 |
$15,717 |
D/D |
(4,242) |
211,445 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
73,000 |
99,700 |
|
- |
|
| Siemers Eric |
Chief Medical Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
94,000 |
120,700 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
91,000 |
117,800 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
106,000 |
215,687 |
|
- |
|
| Oconnell Daniel Joseph |
President and CEO |
• • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
401,000 |
517,685 |
|
- |
|
| Ives Jeffrey L. |
Director |
– • – |
2023-08-17 |
4 |
AS |
$6.48 |
$272,334 |
D/D |
(41,949) |
0 |
|
- |
|
| Ives Jeffrey L. |
Director |
– • – |
2023-08-17 |
4 |
OE |
$0.72 |
$31,519 |
D/D |
41,949 |
2,800 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2023-07-21 |
4 |
B |
$7.75 |
$39,999,998 |
I/I |
5,161,290 |
13,043,179 |
2.25 |
- |
|
| Meisner Derek M |
Chief Legal Office & Corp Sec |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
26,800 |
26,800 |
|
- |
|
| Zuga Matt |
CFO and Chief Business Officer |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
33,500 |
109,687 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
26,700 |
26,700 |
|
- |
|
| Oconnell Daniel Joseph |
President and CEO |
• • – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
114,000 |
116,685 |
|
- |
|
| Siemers Eric |
Chief Medical Officer |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
26,700 |
26,700 |
|
- |
|
| Zuga Matt |
CFO and Chief Business Officer |
• – – |
2022-12-29 |
4 |
OE |
$1.19 |
$59,500 |
D/D |
50,000 |
76,187 |
|
- |
|
| Stalfort Sean |
Director |
– • – |
2021-07-06 |
4 |
A |
$0.00 |
$0 |
I/I |
131,595 |
131,595 |
|
- |
|
| Stalfort Sean |
Director |
– • – |
2021-07-06 |
4 |
B |
$16.00 |
$560,000 |
D/D |
35,000 |
172,324 |
2.39 |
- |
|
| Stalfort Sean |
Director |
– • – |
2021-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
130,180 |
137,324 |
|
- |
|
| Sands Frank M. |
10% Owner |
– – • |
2021-07-06 |
4 |
B |
$14.88 |
$6,696,000 |
D/D |
450,000 |
3,417,075 |
2.45 |
- |
|
| Sands Frank M. |
10% Owner |
– – • |
2021-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,967,075 |
2,967,075 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2021-07-06 |
4 |
A |
$0.00 |
$0 |
I/I |
7,895,773 |
588,850 |
|
- |
|
37 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
